Oaktree Acquisition Corp. III Life Sciences (OACC) 是一家上市公司 属于 金融服务 板块，经营于 壳公司 行业. 公司总部位于 Los Angeles, CA, 美国. 现任CEO为 Mathew Pendo.
OACC 拥有 IPO日期为 2024-12-16, 3 名全职员工, 在 NASDAQ Global Market, 市值为 $263.04M.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
